Visual impairment in immunoglobulin G4‑related disease: A case report

Wang,Xue; Sun,Xuren; Ao,Ran; Zeng,Zilu; Li,Dan; Li,Yiling

doi:10.3892/etm.2021.9633

Visual impairment in immunoglobulin G4‑related disease: A case report

Authors:
- Xue Wang
- Xuren Sun
- Ran Ao
- Zilu Zeng
- Dan Li
- Yiling Li
View Affiliations

Affiliations: Department of Gastroenterology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110000, P.R. China
Published online on: January 11, 2021 https://doi.org/10.3892/etm.2021.9633
Article Number: 200
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study reports on the case of a 50‑year‑old male with sinusitis, diplopia, secretory otitis media and skin eczema for >14 years. The patient presented with visual impairment in both eyes and subxiphoid pain on admission to the First Affiliated Hospital of China Medical University (Shenyang, China). Orbital CT revealed a slightly thickened left inferior rectus muscle. Due to a periocular mass, enlarged lymph nodes, elevated serum immunoglobulin G4 (IgG4) levels and enriched IgG4‑positive plasma cells in the lymph nodes, the diagnosis of IgG4‑related disease (IgG4‑RD), possibly involving at least 10 organs, was established. Following treatment with methylprednisolone, the serum IgG4 levels decreased to normal and binocular vision returned to normal. Unlike previously reported cases, the present case exhibited no swollen masses around the optic nerve. The purpose of the present case report was to improve the understanding of IgG4‑RD.

View Figures

View References

1	Kubo K and Yamamoto K: IgG4-related disease. Int J Rheum Dis. 19:747–762. 2016.PubMed/NCBI View Article : Google Scholar
2	Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, Klöppel G, Heathcote JG, Khosroshahi A, Ferry JA, et al: Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 25:1181–1192. 2012.PubMed/NCBI View Article : Google Scholar
3	Masamune A, Kikuta K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T and Okazaki K: Collaborators. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. J Gastroenterol. 55:462–470. 2020.PubMed/NCBI View Article : Google Scholar
4	Mejico LJ: IgG4-related ophthalmic disease. Saudi J Ophthalmol. 29:53–56. 2015.PubMed/NCBI View Article : Google Scholar
5	Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S, et al: Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 22:21–30. 2012.PubMed/NCBI View Article : Google Scholar
6	Tokura Y, Yagi H, Yanaguchi H, Majima Y, Kasuya A, Ito T, Maekawa M and Hashizume H: IgG4-related skin disease. Br J Dermatol. 171:959–967. 2016.
7	Agaimy A and Ihrler S: Immunoglobulin G4 (IgG4)-related disease. A review of head and neck manifestations. Pathologe. 35:152–159. 2014.PubMed/NCBI View Article : Google Scholar : (In German).
8	Minaga K, Watanabe T, Chung H and Kudo M: Autoimmune hepatitis and IgG4-related disease. World J Gastroenterol. 25:2308–2314. 2019.PubMed/NCBI View Article : Google Scholar
9	Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, Fukushima M, Nikaido T, Nakayama Usuda N and Kiyosawa K: High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 344:732–738. 2001.PubMed/NCBI View Article : Google Scholar
10	Hamano H, Kawa S, Ochi Y, Unno H, Shiba N, Wajiki M, Nakazawa K, Shimojo H and Kiyosawa K: Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 359:1403–1404. 2002.PubMed/NCBI View Article : Google Scholar
11	Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, Okamoto A, Egawa N and Nakajima H: A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 38:982–984. 2003.PubMed/NCBI View Article : Google Scholar
12	Min HK, Lee YS, Yang SW, Lee J, Kwok SK, Ju JH, Kim WU and Park SH: Clinical outcomes and pathological characteristics of immunoglobulin G4-related ophthalmic disease versus orbital inflammatory pseudotumor. Korean J Intern Med. 34:220–226. 2019.PubMed/NCBI View Article : Google Scholar
13	Tiegs-Heiden CA, Eckel LJ, Hunt CH, Diehn FE, Schwartz KM, Kallmes DF, Salomão DR, Witzig TE and Garrity JA: Immunoglobulin G4-related disease of the orbit: Imaging features in 27 patients. Am J Neuroradiol. 35:1393–1397. 2014.PubMed/NCBI View Article : Google Scholar
14	Andrew N, Kearney D and Selva D: IgG4-related orbital disease: A meta-analysis and review. Acta Ophthalmol. 91:694–700. 2013.PubMed/NCBI View Article : Google Scholar
15	Kubota T and Moritani S: Orbital IgG4-related disease: Clinical features and diagnosis. ISRN Rheumatol. 2012(412896)2012.PubMed/NCBI View Article : Google Scholar
16	Takahashi Y, Kitamura A and Kakizaki H: Bilateral optic nerve involvement in immunoglobulin G4-related ophthalmic disease. J Neuroophthalmol. 34:16–19. 2014.PubMed/NCBI View Article : Google Scholar
17	Takahira M, Ozawa Y, Kawano M, Zen Y, Hamaoka S, Yamada K and Sugiyama K: Clinical aspects of IgG4-related orbital inflammation in a case series of ocular adnexal lymphoproliferative disorders. Int J Rheumatol. 2012(635473)2012.PubMed/NCBI View Article : Google Scholar
18	Ramirez L, D'Auria A, Popalzai A and Sanossian N: Bilateral vision loss secondary to pachymeningitis in a patient with IgG4-related disease. Front Neurol. 5(192)2014.PubMed/NCBI View Article : Google Scholar
19	Sogabe Y, Ohshima K, Azumi A, Takahira M, Kase S, Tsuji H, Yoshikawa H and Nakamura T: Location and frequency of lesions in patients with IgG4-related ophthalmic diseases. Graefes Arch Clin Exp Ophthalmol. 252:531–538. 2014.PubMed/NCBI View Article : Google Scholar
20	Zhang W, Luo J and Jiao J: Optic nerve involvement in immunoglobulin G4-related disease: A case report. Exp Ther Med. 12:111–114. 2016.PubMed/NCBI View Article : Google Scholar
21	Li J, Zhang Y, Zhou H, Wang L, Wang Z and Li H: Magnetic resonance imaging indicator of the causes of optic neuropathy in IgG4-related ophthalmic disease. BMC Med Imaging. 19(49)2019.PubMed/NCBI View Article : Google Scholar
22	Yamada K, Yamamoto M, Saeki T, Mizushima I, Matsui S, Fujisawa Y, Hara S, Takahashi H, Nomura H, Kawa S and Kawano M: New clues to the nature of immunoglobulin G4-related disease: A retrospective Japanese multicenter study of baseline clinical features of 334 cases. Arthritis Res Ther. 19(262)2017.PubMed/NCBI View Article : Google Scholar
23	Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, Chari ST, Della-Torre E, Frulloni L, Goto H, et al: International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 67:1688–1699. 2015.PubMed/NCBI View Article : Google Scholar
24	Okazaki K, Chari ST, Frulloni L, Lerch MM, Kamisawa T, Kawa S, Kim MH, Lévy P, Masamune A, Webster G and Shimosegawa T: International consensus for the treatment of autoimmune pancreatitis. Pancreatology. 17:1–6. 2017.PubMed/NCBI View Article : Google Scholar